Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: hormones-everywhere
Load new posts () and activity
Like Reblog Comment
text 2020-02-12 05:31
IV Equipment Market Recent Development | Industry Report 2022

 Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Presently, many companies are developing various infusion devices capable of being integrated with alarm devices, monitoring devices, and data exchange systems.

This integration helps prevent an overdose or reduced dose of infusion solutions to patients and minimizes dosing errors. Major players in the market are focusing on achieving system interoperability of the IV equipment such as infusion pump with EHR technology. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

According to the new market research report " IV Equipment Market by Product (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector), End User (Hospitals & Clinics, Homecare, Ambulatory Care Center) - Global Forecast to 2022", published by MarketsandMarkets™,The overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313


Increasing incidence of chronic diseases drives the global IV equipment market

The global burden of chronic diseases such as heart disease, stroke, cancer, chronic respiratory diseases, and diabetes is increasing rapidly. According to the World Health Organization (WHO) 2015, chronic diseases accounted for approximately 60% of the total reported deaths in the world. The proportion of the burden of chronic diseases (chronic non-communicable diseases) is expected to increase to 57% by 2020 from 46% in 2001.

The risk of chronic diseases increases with age. Among the geriatric population, the prevalence rate of chronic diseases is 64 per 1,000 persons. According to WHO, the global share of the geriatric population (aged 65 years or above) increased from 7.3% in 2005 to 8.7% in 2017 and is expected to continue to grow as a proportion of the world population, reaching 9.3% by 2020.

The following are the major objectives of the study :

To define, describe, and forecast the global IV equipment market on the basis of product, end user, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and trends)
To strategically analyze micromarkets1 and subsegments with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders

Read more: https://www.marketsandmarkets.com/Market-Reports/iv-equipment-market-78345313.html

Some of the prominent players in the global IV equipment market are Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter Interanl Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), Smiths Medical (U.K.), C. R. Bard, Inc. (U.S.), Terumo Corporation (Japan), Moog, Inc. (U.S.), and AngioDynamics, Inc. (U.S.). These players adopted both organic as well as inorganic strategies such as product launches and enhancements, collaborations and agreements, acquisitions and grant to sustain in this market.

Request Sample Report Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=78345313

Source: www.marketsandmarkets.com/Market-Reports/iv-equipment-market-78345313.html
Like Reblog Comment
text 2020-02-05 13:30
Plant Hormones Market Size, Share, Industry Demand, Competitor Landscape, Future Growth, Forecast To 2023

Market Overview
Plant hormones are naturally occurring elements that regulate the development and growth of plants. Plant hormones are either plant-derived or chemical prepared substance used for improving plant growth. Additionally, plant hormones market is observing an exponential growth based on its high usage in the agriculture industry.
The global Plant Hormones Market Size is growing due to demand for organic food. With the growing consumer awareness and their increasing interest in healthy food, the demand for plant hormones has increased recently. In addition to the growing population, the demand for fruit and vegetable, pulses, grains, and other agricultural products are expected to surge the demand for plant hormones over the review period.

The global plant hormones market is projected to propel by the increasing awareness regarding available benefits to the crop producers by the use of the plant hormones. Furthermore, food security for the growing population, advancement in farming practices & technologies, and high opportunities in developing countries is positively supporting the growth of global plant hormones market.

Downstream Analysis
Plant hormones market is segmented on the basis of type, which includes auxins, cytokinins, ethylene, gibberellins, and others. Among all, the cytokinins segment is dominating the market followed by ethylene.

Based on function, the plant hormones market is segmented into growth inhibitors and growth promoters. The growth promoters’ segment is dominating the market owing to increased demand for agricultural products in the growing population.

Based on the formulation, the plant hormones market is segmented into wettable powders, granules, solutions, and others. Among all, the solution segment is dominating the market followed by granules. Granular formulations are relatively stable and easy to use.

Based on application, the plant hormones market is segmented into fruits & vegetables, cereals & pulses, oilseeds and grains, and others. The fruits & vegetable segment is dominating the market owing to growing health consciousness among consumers and increasing consumption of a fruit & vegetable products.

 Competitive Analysis:
The major players in the Plant Hormones Market,

  • BASF SE (Germany)
  • Syngenta AG (Switzerland)
  • The Dow Chemical Company (U.S.)
  • Nufarm Australia Ltd. (Australia)
  • FMC Corporation (U.S.)
  • Bayer CropScience AG (Germany)
  • Adama Agricultural Solutions Ltd. (Israel)
  • Tata Chemicals Ltd. (India)
  • Shanghai Xinyi Industry Co., Ltd. (China)
  • Valent BioSciences Corporation (U.S.)

Access Report Details @ https://www.marketresearchfuture.com/reports/plant-hormones-market-5112

Regional Analysis
The global plant hormones market is segmented into North America, Europe, Asia Pacific, and rest of the world (RoW). The European region is dominating the plant hormones market followed by the Asia Pacific owing to rising population followed by increasing consumption of fruits and vegetables, pluses, grains, and oilseeds in developing regions. Additionally, the major key players are actively involved in the research & developments of the product conforming to European regulations for plant hormones.

Furthermore, shrinking agricultural land in the Asia Pacific region including countries such as China, Japan, and India has uplifted the demand for plant hormones. Also, increasing agricultural activities in developing economies of the Asia Pacific region is adding fuel to the growth of the global plant hormones market.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Like Reblog Comment
text 2020-01-28 10:51
Human Growth Hormone Market Size Expansion to 2023, Growth Indicators, Industry Share, Recent Trends, Demand, Upcoming Innovations by Leading Players and Forecast by MRFR

Human Growth Hormone Market Research Report: Information by Brand (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Others), Application (Growth Hormone Deficiency, Idiopathic, Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, Others), Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Clinics, E-Commerce Websites) and Region - Global Forecast till 2025

The Global Human Growth Hormone Market Size is expected to exhibit a stellar 7.5% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global growth hormone market is mainly driven by the growing research into the potential applications of growth hormones in the healthcare field, which has opened up new vistas for the market in the last few years. The report studies the global growth hormone market in detail to provide indicators as to the market’s likely movement over the forecast period. A detailed statistical analysis of the historical trajectory of the human growth hormone market is presented in the report to explain the market’s growth trajectory. Leading drivers and restraints operating on the global growth hormone market are studied in the report.

The Global Human Growth Hormone Market is mainly driven by the increasing volume of research activities in the field of epigenetics. Increasing research into the genetic makeup of individuals and the expression of genes has resulted in growing application of growth hormones, which are highly useful in curing a number of diseases. The consistent advancement of recombinant DNA technology has made scientists capable of producing high-grade human growth hormones, allowing the use of growth hormones in a wider range of applications.

The growing awareness about growth hormone deficiency diseases is also likely to be a major driver for the global human growth hormone market over the forecast period. Due to the lack of understanding on the precise role of the human growth hormone on the development of the human body, many growth hormone deficiency disorders have remained uncurable for years. However, steady development in recombinant DNA technology has enabled smooth production of growth hormones for clinical applications, resulting in a growing demand from the human growth hormone market.

Human Growth Hormone Market Competitive Analysis:

Leading players in the global human growth hormone market include Zhongshan Hygene Biopharm Co. Ltd., Genentech Inc., Lifetech Labs, GeneScience Pharmaceuticals Co. Ltd., Merck KGaA, Eli Lilly and Company, Ipsen S.A., Biopartners GmbH, Anhui Anke Biotechnology (Group) Co. Ltd., Novartis AG, Pfizer Inc., and Novo Nordisk A/S. Several players in the human growth hormone market have made moves to collaborate with research entities and other players in the last few years in order to achieve mutual benefits. Collaboration is likely to remain a key tactic for players in the human growth hormone market over the forecast period.

In September 2019, a new study published in Aging Cell journal suggested that recombinant human growth hormone (rhGH) can reverse aging. While the study was confined to just nine test subjects, the process is likely to be replicated in larger studies in order to verify the results. If the results hold firm in larger tests, this could represent a major opportunity for the human growth hormone market, as anti-aging medications are likely to remain a cornerstone of the healthcare sector in the coming years.

Browse More Information @ https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494

Human Growth Hormone Market Segmentation:

The global growth hormone market is segmented on the basis of brand, application, route of administration, distribution channel, and region.

On the basis of the brand, the global human growth hormone market is categorized into Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, and others. Norditropin holds a dominant share of more than 37% in the global human growth hormone market.

On the basis of application, the market is segmented into growth hormone deficiency, idiopathic, short stature, small for gestational age, Turner syndrome, Prader-Willi syndrome, and others. Growth hormone deficiency is the largest application of growth hormones, followed by idiopathic short stature and small for gestational age.

On the basis of route of administration, the human growth hormone market is segmented into subcutaneous, intramuscular, intravenous, and oral. Subcutaneous administration holds the largest share in the global growth hormone market.

On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, clinics, e-commerce websites. Hospital pharmacies hold the largest share in the global market.

Human Growth Hormone Market Regional Analysis:

The Americas account for the largest share in the global human growth hormone market, holding 49.18% of the market in 2017. Europe holds the second largest share in the market, followed by Asia Pacific. The Middle East and Africa is the smallest regional market.


Source: www.marketresearchfuture.com/reports/human-growth-hormone-market-6494
Like Reblog Comment
text 2019-11-26 14:30
Bioidentical Hormones Market Analysis, Latest Innovations, Research, Segment, Growth Prediction, Industry Trends, Upcoming Trends And Opportunity Assessment

Global bioidentical hormones market is expected to reach USD 400 million by 2023, and the market is projected to grow at a CAGR of 5.2 % during the forecast period 2017-2023.


Bioidentical Hormones Market Overview

Bioidentical hormones although are created in a lab they are very similar to the hormones produced by the human body.  Hence, they can be defined as man-made hormones. These hormones are customized as per the prescription or are compounded by a pharmacist, based on the doctor’s demand. 


Bioidentical hormones are then used as a treatment for people whose own hormones are imbalanced. Bioidentical hormones just as hormones produced by the human body can control almost all tasks in the body including sex and brain function, growth and the breakdown of food, etc.


Hormonal imbalance can cause increased risks including low energy, weight gain, muscle atrophy, hair loss, depression, anxiety, mood swings, trouble sleeping, and hot/ cold flashes & night sweats for women who are going through their menopause.

People witnessing these symptoms are prescribed with the hormone-replacement therapy where the provider first talks with the patients and asks them to undergo a blood test to determine the specific symptoms and then orders the test.


Get Free PDF Sample Of Bioidentical Hormones Market Research Report- Global Forecast till 2023 https://www.marketresearchfuture.com/sample_request/4187


Unlike, the synthetic hormones, bio-identical hormones do not create any cause side effects and increased risks. These hormones rarely have side effects and, if they do, the provider might need to adjust the dosage. As a result, bio-identical hormones are preferred widely.


Increasing prevalence of hormonal changes or imbalance in hormones led by the sedentary lifestyle, lack of nutrition, and the aging drives the market for bioidentical hormones, creating a huge demand.  Resultantly, the bioidentical hormones market garners huge demand, uptake, and hence the colossal growth on the global platform.

Recognizing the kind of the growth, the market witnesses today, an eminent research firm, Market Research Future (MRFR) in its recently published study report confirms that the global bioidentical hormones market will reach USD 400 MN, registering approximately 5.2 % CAGR during the forecast period (2017-2023).


Additional factors substantiating the market growth include the environmental changes, increasing industrialization and urbanization. Improving economic conditions are certainly providing a vast impetus to the market growth, availing the quality healthcare.

On the other hand, factors such as the demand and supply gap of feedstock required in the production of these hormones are estimated to obstruct the market growth over the forecast period, increasing their prices unreasonably. 


Bioidentical Hormones Global Market – Segmentations

MRFR has segmented the report into four key dynamics for an easy grasp; 

By Types : Estrogens, Progesterone, and Testosterone among others.

By Product Types: Tablets & Capsules, Creams & Gels, Injectable, and Patches & Implants among others.

By End-Users: Hospitals & Gynecology Clinics, Academic and Research among others.

By RegionsEurope, North America, APAC and the Rest-of-the-World. 


Global Bioidentical Hormones Market – Regional Analysis

The North American region dominates the global bioidentical hormones market, in terms of both market size as well as revenue. The extensive use of medications and high expenditure on health care majorly lead the market growth in the region.  Besides, factors such as the fastest uptake of new drugs alongside the presence of major research companies drive the bioidentical hormones market in the region.


The European region accounts for the second-largest market in the world due to high per capita income and healthcare expenditures. A well-developed healthcare sector along with the resurging economy in the region substantiates the market growth of bioidentical hormones in the region. Some of the European countries such as the U.K, Germany, and France boost the market growth in this region.


The Asia Pacific region accounts for a promising market for bioidentical hormones, closely following the European market. Factors such as the ever-increasing population encourage the use to bioidentical hormones, creating a significant demand for healthcare. China and India backed by their respective, fast-growing healthcare sector will be leading the APAC bioidentical hormones market. 


Global Bioidentical Hormones Market – Competitive Analysis

Highly competitive bioidentical hormones market appears fragmented due to the presence of several large and small-scale players. Producers compete based upon price and brand, emphasizing upon new product development initiatives, and geographical expansion. Matured players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain a competitive advantage and thus to maintain their positions in this market.


Key Players:

Some of the eminent leaders of the market include BioTE Medical, SottoPelle, Advantage Pharmaceuticals, Inc., Neuva Aesthetics, Full Life Wellness Center, Defy Medical, and Biostation.


Industry/ Innovation/ Related News:

October 29, 2018 – TherapeuticsMD Inc. (US) a leading global Pharmaceutical company announced receiving its third FDA approval of the year, Bijuva, a menopause remedy that combines two bioidentical hormones.


Bijuva, an oral soft gel that contains ingredients are artificially produced but chemically identical to hormones made naturally by women's bodies such as estradiol and progesterone which are commonly used in hormone therapies to treat menopause symptoms such as hot/cold flashes. The company is now all geared up to launch first-ever bioidentical hormone combo Bijuva.


Browse the market data and information spread across 80 pages with data tables and figures of the report “Bioidentical Hormones Market Information: By Types (Estrogens, Progesterone, Testosterone, others) By Product Types (Tablets and Capsules, Creams and Gels, Injectable, Patches and Implants, and others) By End Users Global Forecast Till 2023” in-depth alongside table of content (TOC) at:  https://www.marketresearchfuture.com/reports/bioidentical-hormones-market-4187

Like Reblog Comment
text 2018-12-26 09:05
Bioidentical Hormones Market

Bioidentical hormones are hormones that are chemically the same as those that the body produces. Although they are made in a laboratory, bioidentical hormones mimic the hormones the human body produces naturally.
The global Bioidentical Hormones market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 20192025. The objectives of this study are to define, segment, and project the size of the Bioidentical Hormones market based on company, product type, end user and key regions.

This report studies the global market size of Bioidentical Hormones in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bioidentical Hormones in these regions.
This research report categorizes the global Bioidentical Hormones market by top players/brands, region, type and end user. This report also studies the global Bioidentical Hormones market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BioTE Medical
Advantage Pharmaceuticals
Full Life Wellness Center
Neuva Aesthetics
Defy Medical

Market size by Product
Market size by End User
Hospitals & gynecology clinics
Academic and research

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:
To study and analyze the global Bioidentical Hormones market size value & volume by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bioidentical Hormones market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industryspecific challenges and risks.
Focuses on the key global Bioidentical Hormones companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bioidentical Hormones submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bioidentical Hormones are as follows:
History Year: 20142018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value million US$ and volume K Units. Both topdown and bottomup approaches have been used to estimate and validate the market size of Bioidentical Hormones market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Source: www.qandqmarketresearch.com
More posts
Your Dashboard view:
Need help?